Designing a Defensible In-Vitro Study
Controls, replication, and endpoint selection — the structural decisions that determine whether a result means anything.
Start from the endpoint
All material below describes laboratory handling and analytical practice for reference compounds supplied strictly for in-vitro research. Nothing here is guidance for human or animal use.
Design backwards. Name the measurable quantity first — phosphorylated AMPK by Western blot, VEGF by ELISA, neurite length by imaging, oxygen consumption rate by extracellular flux — and only then design the conditions around it. Studies that begin with a compound rather than a question generate data that cannot be interpreted in either direction.
A good endpoint is proximal to the mechanism you are probing, quantitative rather than categorical, and measurable with an assay whose dynamic range you have already characterized.
Controls are the experiment
Each control excludes a specific alternative explanation. Omitting one does not simplify the study; it deletes a conclusion.
- Vehicle control — diluent alone, including any co-solvent, at matched volume. Benzyl alcohol is not inert in every cell line.
- Negative control — untreated cells, establishing baseline drift across the plate and the timecourse.
- Positive control — a compound with a known, published response in your system, proving the assay was capable of detecting an effect that day.
- Concentration series — a minimum of five points spanning at least three log units, so you obtain a curve rather than an anecdote.
Replication and plate layout
Technical replicates measure your pipetting; biological replicates measure the biology. Only the latter supports a claim. Run at least three independent biological replicates on separate passages and separate days.
Randomize condition placement across the plate rather than filling column by column. Edge wells evaporate faster, and a systematic layout converts that physical gradient into a false dose response. Where possible, blind the analyst to condition identity at the point of measurement.
Reporting
Report the compound lot number, the assay method and its parameters, the exact concentrations tested, the number and type of replicates, and the statistical test with its assumptions. Publish the negative results from the same series — a concentration range where nothing happened is genuine information about the system, and its absence is how selective reporting begins.
Compliance boundary
Reference compounds supplied by Affluent Society are for in-vitro laboratory investigation only. They are not drugs, supplements, cosmetics, or food, and they are not for human or animal administration. Institutional review, biosafety approval, and jurisdictional compliance remain the responsibility of the purchasing laboratory.